PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 13, 2004Neurology156 citations

A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation

View Full Paper
RBRenato BorgattiCZClaudio ZuccaACAnna Cavallini

Key Result

A novel KCNQ2 K526N missense mutation was identified in four family members with BFNC, which altered the voltage-dependence of activation of potassium channels in vitro.

Study Design

Type

Case Report (n=4)

Structured PICO

P
Population
4 family members affected by Benign familial neonatal convulsion (BFNC) presenting with variable neurologic symptoms.
E
Exposure
KCNQ2 K526N missense mutation
C
Comparator
Wild-type KCNQ2 and KCNQ3 subunits
O
Outcome
Voltage-dependence of activation, intracellular trafficking, and plasma membrane expression of potassium channelssurrogate

The novel KCNQ2 K526N mutation alters M-channel function and may explain the phenotypic variability of neurologic symptoms in BFNC.

Abstract

BACKGROUND: Benign familial neonatal convulsion (BFNC) is a rare autosomal dominant disorder caused by mutations in two genes, KCNQ2 and KCNQ3, encoding for potassium channel subunits underlying the M-current. This current limits neuronal hyperexcitability by causing spike-frequency adaptation. METHODS: The authors describe a BFNC family with four affected members: two of them exhibit BFNC only while the other two, in addition to BFNC, present either with a severe epileptic encephalopathy or with focal seizures and mental retardation. RESULTS: All affected members of this family carry a novel missense mutation in the KCNQ2 gene (K526N), disrupting the tri-dimensional conformation of a C-terminal region of the channel subunit involved in accessory protein binding. When heterologously expressed in CHO cells, potassium channels containing mutant subunits in homomeric or heteromeric configuration with wild-type KCNQ2 and KCNQ3 subunits exhibit an altered voltage-dependence of activation, without changes in intracellular trafficking and plasma membrane expression. CONCLUSION: The KCNQ2 K526N mutation may affect M-channel function by disrupting the complex biochemical signaling involving KCNQ2 C-terminus. Genetic rather than acquired factors may be involved in the pathophysiology of the phenotypic variability of the neurologic symptoms associated with BFNC in the described family.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Borgatti et al. (2004) conducted a case report in Benign familial neonatal convulsion (BFNC) (n=4). KCNQ2 K526N mutation was evaluated on Potassium channel function and clinical phenotype. A novel KCNQ2 K526N missense mutation was identified in four family members with BFNC, which altered the voltage-dependence of activation of potassium channels in vitro.

synapsesocial.com/papers/6a9b6792a7e2c1a176497819https://doi.org/10.1212/01.wnl.0000132979.08394.6d
Ask AI
Helpful
Bookmark
Share
View Full Paper